Description

IVERHEAL 1% CREAM 30GM

Indications

IVERHEAL 1% Cream is primarily indicated for the treatment of various parasitic infections, specifically those caused by ectoparasites such as scabies and lice. It is also utilized in the management of skin conditions associated with these infestations. The active ingredient, Ivermectin, is effective in eliminating adult parasites and their larvae, providing relief from associated symptoms such as itching and inflammation.

Mechanism of Action

Ivermectin, the active component of IVERHEAL 1% Cream, works by binding to specific ion channels in the nerve and muscle cells of parasites. This binding leads to an increase in permeability of the cell membranes to chloride ions, resulting in paralysis and death of the parasites. The action of Ivermectin is particularly effective against a range of ectoparasites, disrupting their ability to reproduce and causing them to be expelled from the host’s skin.

Pharmacological Properties

IVERHEAL 1% Cream is a topical formulation that allows for localized treatment of parasitic infections. The cream is designed for easy application and absorption into the skin, where it exerts its therapeutic effects. Ivermectin is known for its broad-spectrum activity against various parasites, including Sarcoptes scabiei (scabies) and Pediculus humanus capitis (head lice). The pharmacokinetics of Ivermectin indicate that it is minimally absorbed through the skin, which helps to reduce systemic side effects while maximizing local efficacy.

Contraindications

IVERHEAL 1% Cream should not be used in individuals with a known hypersensitivity to Ivermectin or any of the other components of the cream. Additionally, it is contraindicated in patients with certain skin conditions or infections that may be exacerbated by topical treatments. Pregnant and breastfeeding women should consult their healthcare provider before using this product, as the safety of Ivermectin in these populations has not been fully established.

Side Effects

The use of IVERHEAL 1% Cream may be associated with some side effects, although they are generally mild and localized. Common side effects include:

• Skin irritation or rash at the application site
• Itching or burning sensation
• Dryness or peeling of the skin

In rare cases, more severe reactions such as allergic dermatitis may occur. If any severe side effects or signs of an allergic reaction appear, it is essential to discontinue use and seek medical attention immediately.

Dosage and Administration

For optimal results, IVERHEAL 1% Cream should be applied topically to the affected areas of the skin. The recommended dosage is to apply a thin layer of cream to the affected area once a day for a duration determined by the healthcare provider, typically ranging from 1 to 2 weeks depending on the severity of the infestation. It is important to follow the healthcare provider’s instructions regarding the duration and frequency of application to ensure effective treatment and minimize the risk of side effects.

Interactions

There are currently no well-documented drug interactions specifically associated with IVERHEAL 1% Cream. However, patients should inform their healthcare provider of all medications, supplements, and topical products they are using to avoid potential interactions. Caution is advised when using other topical treatments simultaneously, as they may affect the efficacy of IVERHEAL or increase the risk of skin irritation.

Precautions

Prior to using IVERHEAL 1% Cream, it is important to conduct a thorough assessment of the patient’s medical history and current medications. Patients with a history of skin conditions, compromised skin integrity, or other underlying health issues should use this product with caution. It is advisable to perform a patch test before widespread application to check for any adverse reactions. Additionally, patients should be educated on proper application techniques and the importance of adhering to the prescribed treatment regimen to ensure the best outcomes.

Clinical Studies

Clinical studies have demonstrated the efficacy of Ivermectin in treating scabies and lice infestations. In a randomized controlled trial, patients treated with Ivermectin showed significant improvement in symptoms and reduction in parasite load compared to those receiving placebo. Furthermore, the topical formulation of IVERHEAL 1% Cream has been shown to provide effective localized treatment with minimal systemic absorption, thereby reducing the risk of systemic side effects. Ongoing research continues to explore the full therapeutic potential of Ivermectin in dermatological applications.

Conclusion

IVERHEAL 1% Cream is an effective topical treatment for managing parasitic infections such as scabies and lice. With its well-established mechanism of action and favorable safety profile, it offers a valuable option for patients seeking relief from these conditions. As with any medication, it is crucial to use IVERHEAL as directed by a healthcare professional to ensure optimal results and minimize potential side effects. Patients are encouraged to discuss any concerns or questions about their treatment with their healthcare provider.